Cargando…
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule
Restoration of the p53 pathway, namely by reactivation of mutant (mut) p53, represents a valuable anticancer strategy. Herein, we report the identification of the enantiopure tryptophanol-derived oxazoloisoindolinone SLMP53-1 as a novel reactivator of wild-type (wt) and mut p53, using a yeast-based...
Autores principales: | Soares, Joana, Raimundo, Liliana, Pereira, Nuno A.L., Monteiro, Ângelo, Gomes, Sara, Bessa, Cláudia, Pereira, Clara, Queiroz, Glória, Bisio, Alessandra, Fernandes, João, Gomes, Célia, Reis, Flávio, Gonçalves, Jorge, Inga, Alberto, Santos, Maria M.M., Saraiva, Lucília |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826208/ https://www.ncbi.nlm.nih.gov/pubmed/26735173 http://dx.doi.org/10.18632/oncotarget.6775 |
Ejemplares similares
-
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
por: Gomes, Sara, et al.
Publicado: (2019) -
SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent Manner
por: Ramos, Helena, et al.
Publicado: (2020) -
DIMP53‐1: a novel small‐molecule dual inhibitor of p53–MDM2/X interactions with multifunctional p53‐dependent anticancer properties
por: Soares, Joana, et al.
Publicado: (2017) -
Structural and Drug Targeting Insights on Mutant p53
por: Gomes, Ana Sara, et al.
Publicado: (2021) -
Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance
por: Loureiro, Joana B., et al.
Publicado: (2021)